Significance of inflammatory biomarkers in assessment of weight reduction in obese children with Down syndrome
DOI:
https://doi.org/10.56511/JIPBS.2019.v6.i02.pp06-09Abstract
Objectives: The present study is designed to evaluate the effect of diet alone or in combination with physical therapy in obese children with Down syndrome. Material and Methods: 60 obese children (30 males+30 females) with Down syndrome (DS) before diet and therapy was subjected to clinical examination. They were divided into three groups matched in age and sex, group I (control), included 20 of them. The other 40 were divided into 2 groups, group IIA and group IIB, each of them 20. Group IIA was subjected to diet intervention program only while group IIB was subjected to both diet and physical therapy programs. Blood samples were obtained from all groups before and after therapy. Plasma levels of leptin, IL-1 and IL-6 were determined. Results: The study found significant weight reduction in both groups favoring combined diet and physical activity. Diet lowered but not significantly the plasma levels of leptin hormone, IL-1 and IL-6. While the diet and physical therapy in combination reduced significantly the plasma levels of leptin, IL-1 and IL-6. Conclusions: The combination of physical activity with nutritional intervention is an effective method for weight reduction in obese children with DS. One of the most objective parameter for the benefit of weight reduction is the inflammatory biomarkers, leptin, IL-1, and IL-6 in the early school age (6-9 years).
Keywords:
Secondary obesity, diet intervention, physical therapy, Down syndrome, inflammatory biomarkersDownloads
References
Ando S, Gelsomino L, Panza S, Giordano C, Bonfigilio D, Baron I and Catalano S: Obesity, leptin and breast cancer: epidemiological evidence and proposed mechanisms. Cancers 2019; 11(62):127.
Wang F, Wild TC, Kipp W, Kuhle S and Veugelers PJ: The influence of childhood obesity on the development of self-esteem. Health Reports 2009; 20(2): 2127.
Bandini LG, Curtin C, Hamad C, Tybor DJ and Must A: Prevalence of overweight in children with developmental disorders in the continuous national health and nutrition examination survey (NHANES) 19992002. J Pediatr 2005; 146: 738743.
Restivo MR, McKinnon MC, Frey BN, Hall GB and Taylor VH: Effect of obesity on cognition in adults with and without a mood disorder: study design and methods. BMJ Open 2016; 29; 6(2): e009347.
Davis CL and Cooper S: Fitness, fatness, cognition, behavior, and academic achievement among overweight children: do cross-sectional associations correspond to exercise trial outcomes?. Preventive Medicine 2011; 52: S65 – S69.
Schwartz DHG, Leonard M and Perron et al.: Visceral fat is associated with lower executive functioning in adolescents. International Journal of Obesity 2013; 37(10): 1336 – 1343.
Helma BM, van Gameren-Oosterom, Paula van Dommelen, Yvonne Schönbeck, Anne Marie, Oudesluys-Murphy, Jacobus P, van Wouwe and Simone EB: Prevalence of overweight in dutch children with Down syndrome. Pediatrics 2012; 130: e1520 – e1526.
Mark RE and Griffin WS: Trisomy 21 and the brain. J Neuropathol Exp Neurol 2004; 63: 679685.
Naerland T, Bakke KA, Storvik S, Warner G and Howlin P: Age and gender-related differences in emotional and behavioural problems and autistic features in children and adolescents with Down syndrome: a survey-based study of 674 individuals. J Intellect Disabil Res 2017; 61(6):594-603.
Kenis G, Teunissen CH and De Jongh R et al.: Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10, and CC16 in human serum. Cytokine 2002; 19: 228235.
Smigielska-Kuzia J, Sendrowski K, Jakubiuk-Tomaszuk A, Bockowski L, Olchowik B and Cholewa M et al.: Proinflammatory plasma cytokines in patients with Down syndrome. Neurologia Dziecieca 2012; 21: 1925.
Park E, Alberti J and Mehta P et al.: Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down’s syndrome. Clin Immunol 2000; 95: 6269.
Zemel BS, PipanM, Stallings VA, Hall W and Schadt K et al.: Growth Charts for Children with Down syndrome in the United States. Pediatrics 2015; 136: 12041211.
Artioli T: Understanding obesity in Down’s syndrome children. J Obes Metab 2017; 1(1): 1-3.
Barlow SE and the Expert Committee: Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007; 120: S164 — S192.
Eknoyn GP and Gorabed SN: Neurohormonalcytokine interactions: implications for inflammation. common human diseases and well-beigg. Neurochem Int 2008; 52: 4051.
Christopher Duggan, John, B, Watkins W and Allan Walker: Health and Fitness, 2008.
Rauch F: Vibration therapy. Dev Med Child Neurol 2009; 51(4): 166168.
Waddington GS and Adams RD: The effect of a 5week whole-board exercise intervention on ability to discriminate different degrees of ankle inversion, barefoot and wearing shoes: a study in healthy elderly. Journal of the American Geriatrics Society 2004; 52(4): 573576.
Laufer Y, Dickstein R, Chefez Y and Marcovitz E: The effect of treadmill training on the ambulation of stroke survivors in the early stages of rehabilitation. A randomized study 2001; 38(1): 6978.
Cesari P, Formenti F and Olivato P: A common perceptual parameter for stair climbing for children, young and old adults. Human Movement Science 2003; 22: 111124.
Londraville RL et al.: Comparative endocrinology for leptin: assessing function in a phylogenetic context. Gen Comp Endocrinol 2014; 203: 146157.
Bjorbaek C and Kahn BB: Leptin signaling in the central nervous system and the periphery. Recent Prog Hom Res 2004; 59: 305332.
Cooper-Brown L, Copeland S, Daiiley S, Downey D and Petersen MC et al.: Feeding and swallowing dysfunction in genetic syndromes. Dev Disabil Res Rev 2008; 14: 147-157.
Wong C, Dwyer J and Holland M: Overcoming weight problems in adults with Down syndrome. Nutrition Today 2014; 49(3): 109119.
Melville C, Cooper SA, Morrison J, Allan L, Smiley E and Williamson A: The prevalence and determinants of obesity in adults with intellectual disabilities. J Appl Res Intellect Disabil 2007; 21 (5): 425437.
Bull MJ: Health supervision for children with Down Syndrome. Pediatrics 2011; 128: 393406.
Prickett C, Brennan L and Stolwyk R: Examining the relationship between obesity and cognitive function: a systematic literature review. Obesity Research and Clinical Practice 2015; 9( 2): 93 – 113.
Dahl AK and Hassing LB: Obesity and cognitive aging. Epidemiologic Reviews 2013; 35 (1): 22 – 32.
Francis H and Stevenson R: The longer-term impacts of Western diet on human cognition and the brain. Appetite 2013; 63: 119 – 128.
Laudisio D, Muscogiuri G, Barrea I, Savastano S and Colao A: Obesity and breast cancer in premenopausal women: current evidence and further perspectives. Eur J Obstet Gynecol Reprod Biol 2018; 230: 217221.
Carta MG, Serra P and Ghiani A et al.: Chemokines and proinflammatory cytokines in Down’s syndrome: an early marker for Alzheimer-type dementia?. Psychother Psychosom 2002; 71: 233236.
Sridevi S, Adalarasan N, Babu RN, Sathyamurthi B, Seeralar ATA, Srilakshmi R and Anadan H: Serum leptin levels in Down’s syndrome versus normal children. International Journal of Scientific Study 2016; 4(2): 175178.
Isaac VS, Sim H, Zheng V, Zagorodnov E, Shyong Tai and Chee M: Adverse associations between visceral adiposity, brain structure, and cognitive performance in healthy elderly. Frontiers in Aging Neuroscience 2011; 3: 1218.
Published
How to Cite
Issue
Section
Copyright (c) 2019 Mohamed E. Elhadidy, Ayman Kilany, Hend Rashad, Fateheya M. Metwally, Adel Hashish, Ahmed Mashaal, Ehab Abdelraouf
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at